tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Drew Jones, 7 are a BUY (77.78%), 2 are a HOLD (22.22%).
Analyst Drew Jones, currently employed at STEPHENS, carries an average stock price target met ratio of 82.22% that have a potential upside of 26.58% achieved within 340 days. Previously, Drew Jones worked at DEUTSCHE BANK.
Drew Jones’s has documented 25 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LGND, Ligand Pharmaceuticals orporated at 03-May-2019.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $54 was fulfilled within 1 day with a profit of $0.99 (1.8%) receiving and performance score of 18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$75
$22.09 (41.75%)
$85
13 days ago
(11-Nov-2024)
4/9 (44.44%)
$23.67 (46.11%)
31
Buy
$65
$12.09 (22.85%)
$67
18 days ago
(06-Nov-2024)
10/12 (83.33%)
$14.51 (28.74%)
151
Buy
$67
$14.09 (26.63%)
$75
18 days ago
(06-Nov-2024)
9/10 (90%)
$16.51 (32.70%)
77
Buy
$65
$12.09 (22.85%)
$75
18 days ago
(06-Nov-2024)
0/5 (0%)
$14.51 (28.74%)
Buy
$75
$22.09 (41.75%)
$95
18 days ago
(06-Nov-2024)
2/11 (18.18%)
$24.51 (48.54%)
39
What Year was the first public recommendation made by Drew Jones?
